Loading

From the DREAM challenge to 1 million mammograms a year: The journey of a start-up that built an AI for breast cancer detection

Retour

On the occasion of Thérapixel’s victory in the DREAM Mammography Challenge, Pierre Fillard, co-founder of Thérapixel, will present MammoScreen, a new AI-based software designed for healthcare professionals to facilitate breast cancer detection

 

 

 

 

 

Founded in 2013 by Pierre Fillard and Olivier Clatz, Thérapixel develops AI to facilitate the reading of medical images for professionals.

 

One in eight women is affected by breast cancer (ARC Foundation), making early detection a major public health issue.

 

Winner of the DREAM Mammography Challenge, Pierre Fillard will present MammoScreen, a screening software based on deep learning. Based on 2D and 3D mammograms, tomosynthesis and previous examinations, it generates an indicative score to assist doctors, improve individual performance and reduce variability between readers.

 

 

 

 

 

To find out more, come and see us :

🕚 7th of November, 11 a.m.–12 p.m.

📍 ED50 room (Bâtiment ED, Campus Carreire)